Wells Fargo Downgrades Applied Genetic to Equal-Weight, Lowers Price Target to $0.5
Wells Fargo analyst Yanan Zhu downgrades Applied Genetic (NASDAQ:AGTC) from Overweight to Equal-Weight and lowers the price target from $12 to $0.5.
Current Valuations Are ‘Quite Expensive’: Why This Livent Analyst Is Bearish
Livent Corp. (NYSE: LTHM) spot prices already reflect scarcity value and “not what is grounded by marginal producer economics,” according to Bank of America Securities (BofA).
Argus Research Downgrades Nike to Hold
Argus Research analyst John Staszak downgrades Nike (NYSE:NKE) from Buy to Hold.
Scotiabank Downgrades Saputo to Sector Perform, Lowers Price Target to C$37
Scotiabank analyst George Doumet downgrades Saputo (TSX:SAP) from Sector Outperform to Sector Perform and lowers the price target from C$40 to C$37.
Benchmark Downgrades National CineMedia to Hold
Benchmark analyst Mike Hickey downgrades National CineMedia (NASDAQ:NCMI) from Buy to Hold.
B of A Securities Downgrades Livent to Underperform, Lowers Price Target to $27
B of A Securities analyst Matthew DeYoe downgrades Livent (NYSE:LTHM) from Neutral to Underperform and lowers the price target from $31 to $27.
Goldman Sachs Downgrades Citigroup to Neutral, Lowers Price Target to $47
Goldman Sachs analyst Richard Ramsden downgrades Citigroup (NYSE:C) from Buy to Neutral and lowers the price target from $54 to $47.
RBC Capital Downgrades Mosaic to Sector Perform, Lowers Price Target to $65
RBC Capital analyst Andrew Wong downgrades Mosaic (NYSE:MOS) from Outperform to Sector Perform and lowers the price target from $85 to $65.
Keybanc Downgrades Schneider National to Sector Weight
Keybanc analyst Todd Fowler downgrades Schneider National (NYSE:SNDR) from Overweight to Sector Weight.
Why These 2 Apple Analysts Are Moving In Opposite Directions Thursday
Apple Inc (NASDAQ: AAPL) stock was re-rated by two analyst firms, making nearly mirror opposite adjustments to the Cupertino-based company.